Literature DB >> 9652993

Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Department of Health and Human Services and the Henry J. Kaiser Family Foundation.

.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9652993     DOI: 10.7326/0003-4819-128-12_part_2-199806151-00003

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  20 in total

1.  Benchmarks for antiretroviral therapy.

Authors:  O J Cohen; A S Fauci
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

2.  Medication Adherence Among HIV-Infected Patients: Understanding the Complex Behavior of Patients Taking This Complex Therapy.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

Review 3.  Clinical management of treatment-experienced, HIV/AIDS patients in the combination antiretroviral therapy era.

Authors:  Mark A Boyd; Andrew M Hill
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

4.  Effectiveness of highly active antiretroviral therapy among HIV-1 infected women.

Authors:  S J Gange; Y Barrón; R M Greenblatt; K Anastos; H Minkoff; M Young; A Kovacs; M Cohen; W A Meyer; A Muñoz
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

5.  HIV protease inhibitors, indinavir or nelfinavir, augment antimalarial action of artemisinin in vitro.

Authors:  Lokesh C Mishra; Amit Bhattacharya; Manish Sharma; Virendra K Bhasin
Journal:  Am J Trop Med Hyg       Date:  2010-01       Impact factor: 2.345

Review 6.  Tolerabilities of antiretrovirals in paediatric HIV infection.

Authors:  Daniel Avi Lemberg; Pamela Palasanthiran; Michele Goode; John B Ziegler
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

7.  HIV-1 genotypic resistance patterns predict response to saquinavir-ritonavir therapy in patients in whom previous protease inhibitor therapy had failed.

Authors:  A R Zolopa; R W Shafer; A Warford; J G Montoya; P Hsu; D Katzenstein; T C Merigan; B Efron
Journal:  Ann Intern Med       Date:  1999-12-07       Impact factor: 25.391

8.  Expectancy and readiness-based predictors of treatment uptake among the urban poor living with HIV.

Authors:  Mallory O Johnson; Samantha E Dilworth; Eunice Stephens; Paula J Lum; Torsten B Neilands
Journal:  J Acquir Immune Defic Syndr       Date:  2011-12-15       Impact factor: 3.731

9.  HAART-associated dyslipidemia varies by biogeographical ancestry in the multicenter AIDS cohort study.

Authors:  Matthew J Nicholaou; Jeremy J Martinson; Alison G Abraham; Todd T Brown; Shehnaz K Hussain; Steven M Wolinsky; Lawrence A Kingsley
Journal:  AIDS Res Hum Retroviruses       Date:  2013-03-08       Impact factor: 2.205

10.  Disparities in HIV treatment and physician attitudes about delaying protease inhibitors for nonadherent patients.

Authors:  Mitchell D Wong; William E Cunningham; Martin F Shapiro; Ronald M Andersen; Paul D Cleary; Naihua Duan; Hong Hu Liu; Ira B Wilson; Bruce E Landon; Neil S Wenger
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.